Healthy volunteers |
19.9 |
Standardized extract G. biloba (GK501) 120, 240 and 320 mg single doses, once a day |
Better cognitive performance |
Scholey and Kennedy (2002)
|
Healthy volunteers - 20 |
21.2 |
Standardized extract G. biloba (GK501) 360 mg single dose |
Improvement of cognitive abilities, self-esteem and mood |
Kennedy et al. (2002)
|
Healthy volunteers - 20 (study 1) - 28 (study 2) - 30 (study 3) |
19.9 (study 1) 20.4 (study 2) 21.68 (study 3) |
Standardized extract G. biloba (GBE) 120 mg once daily |
Increasing attention efficiency, improving “memory quality”. The effect was most pronounced at 1 and 4 h post-dose |
Kennedy et al. (2007)
|
Healthy volunteers/students - 52 |
18–26 |
Standardized extract G. biloba (LI1370) 120 mg/day for 6 weeks |
Increased performance in cognitive tasks related to memory and attention maintenance, as found in pattern recognition. The effect was visible 4 hours after dosing |
Elsabagh et al. (2005)
|
Patients with dementia - 222 |
>55 |
EGb 761 at 240 mg once daily for 24 weeks |
Improvement of cognitive functions |
Kanovski and Hoerr (2003)
|
Patients with mild to moderate dementia related to neuropsychiatric symptoms (AD or vascular dementia) - 410 |
>50 |
EGb 761 at 240 mg once daily for 24 weeks |
Improvement in cognition, psychopathology, functional measurements and quality of life |
Herrschaft et al. (2012)
|
Patients with mild to moderate dementia AD, vascular dementia, or mixed character - 410 |
>50 |
EGb 761 at 240 mg once daily for 24 weeks |
Improvement of cognitive abilities, neuropsychiatric symptoms, functional capacity and general condition |
Ihl et al. (2011)
|
Patients with mild to moderate dementia with neuropsychiatric features - 400 |
>50 |
EGb 761 at 240 mg once daily for 22 weeks |
Overall improvement of cognitive functions |
Napryeyenko and Borzenko (2007)
|
Patient with AD |
>50 |
EGb 761, 240 mg/day for at least 22 weeks |
Overall improvement of cognitive functions |
Napryeyenko et al. (2009)
|
Elderly people with normal cognition or mild cognitive impairment - 3,069 |
72–96 |
G. biloba extract 120 mg twice a day |
No significant change in cognitive function |
Snitz et al. (2009)
|
People with very mild cognitive impairment - 300 |
45–65 |
EGb 761 at 240 mg once daily for 12 weeks |
Improvement of cognitive functions, concentration as well as memory tasks related to everyday life and quality of life |
Grass-Kanapke et al. (2011)
|
Patients with mild to moderate dementia - 25 |
50–80 |
EGb 761 at 160 mg once daily for 24 weeks |
There was no significant difference between EGb 761 and donepezil in the treatment of mild to moderate dementia |
Mazza et al. (2006)
|
Patients with cognitive impairment and dementia |
25–61 |
EGb 761 at 240 mg once daily for 22–26 weeks |
Stabilized or slowed decline in cognition function |
Tan et al. (2015)
|
Patients with cognitive impairment and dementia - 60 |
50–65 |
EGb 761 at 240 mg once a day for 56 ± 4 days |
Greater cognitive flexibility without altering brain activity in the elderly |
Beck et al, (2016)
|
Patients with AD - 400 |
>50 |
EGb 761 at 240 mg once daily for 22 weeks |
Less apathy and indifference, reduced anxiety, depression and irritability, and improved sleep |
Scripnikov et al. (2007)
|
Healthy elderly or with mild cognitive impairment -3,069 |
>75 |
G. biloba extracts at 120 mg twice daily |
EGb 761 was no better than placebo in reducing the rate of dementia progression in both elderly and AD patients |
DeKosky et al. (2008)
|